These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27805596)

  • 21. High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
    Vazquez-Lombardi R; Jung JS; Schlatter FS; Mei A; Mantuano NR; Bieberich F; Hong KL; Kucharczyk J; Kapetanovic E; Aznauryan E; Weber CR; Zippelius A; Läubli H; Reddy ST
    Immunity; 2022 Oct; 55(10):1953-1966.e10. PubMed ID: 36174557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors.
    Guo T; Chamoto K; Nakatsugawa M; Ochi T; Yamashita Y; Anczurowski M; Butler MO; Hirano N
    PLoS One; 2016; 11(5):e0156114. PubMed ID: 27213277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.
    Ivanov R; Hol S; Aarts TI; Hagenbeek A; Ebeling SB
    Clin Exp Immunol; 2006 Jan; 143(1):78-84. PubMed ID: 16367937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells.
    Tan MP; Gerry AB; Brewer JE; Melchiori L; Bridgeman JS; Bennett AD; Pumphrey NJ; Jakobsen BK; Price DA; Ladell K; Sewell AK
    Clin Exp Immunol; 2015 May; 180(2):255-70. PubMed ID: 25496365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.
    Kunert A; van Brakel M; van Steenbergen-Langeveld S; da Silva M; Coulie PG; Lamers C; Sleijfer S; Debets R
    J Immunol; 2016 Sep; 197(6):2541-52. PubMed ID: 27489285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promiscuous behavior of HPV16E6 specific T cell receptor beta chains hampers functional expression in TCR transgenic T cells, which can be restored in part by genetic modification.
    Scholten KB; Ruizendaal JJ; Graf M; Schoedl T; Kramer D; Meijer CJ; Man S; Hooijberg E
    Cell Oncol; 2010; 32(1-2):43-56. PubMed ID: 20208133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells.
    Sommermeyer D; Uckert W
    J Immunol; 2010 Jun; 184(11):6223-31. PubMed ID: 20483785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.
    Circosta P; Granziero L; Follenzi A; Vigna E; Stella S; Vallario A; Elia AR; Gammaitoni L; Vitaggio K; Orso F; Geuna M; Sangiolo D; Todorovic M; Giachino C; Cignetti A
    Hum Gene Ther; 2009 Dec; 20(12):1576-88. PubMed ID: 19678763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
    Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
    Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique features of the TCR repertoire of reactivated memory T cells in the experimental mouse tumor model.
    Kalinina A; Persiyantseva N; Britanova O; Lupyr K; Shagina I; Khromykh L; Kazansky D
    Comput Struct Biotechnol J; 2023; 21():3196-3209. PubMed ID: 37333858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of higher affinity T cell receptors by antigen-driven differentiation of progenitor T cells in vitro.
    Schmitt TM; Aggen DH; Ishida-Tsubota K; Ochsenreither S; Kranz DM; Greenberg PD
    Nat Biotechnol; 2017 Dec; 35(12):1188-1195. PubMed ID: 29106410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer.
    Ochi T; Fujiwara H; Yasukawa M
    Expert Opin Biol Ther; 2011 Jun; 11(6):699-713. PubMed ID: 21413911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.
    Knies D; Klobuch S; Xue SA; Birtel M; Echchannaoui H; Yildiz O; Omokoko T; Guillaume P; Romero P; Stauss H; Sahin U; Herr W; Theobald M; Thomas S; Voss RH
    Oncotarget; 2016 Apr; 7(16):21199-221. PubMed ID: 27028870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
    Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
    J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
    Tan AT; Yang N; Lee Krishnamoorthy T; Oei V; Chua A; Zhao X; Tan HS; Chia A; Le Bert N; Low D; Tan HK; Kumar R; Irani FG; Ho ZZ; Zhang Q; Guccione E; Wai LE; Koh S; Hwang W; Chow WC; Bertoletti A
    Gastroenterology; 2019 May; 156(6):1862-1876.e9. PubMed ID: 30711630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens.
    Kirschner A; Thiede M; Blaeschke F; Richter GH; Gerke JS; Baldauf MC; Grünewald TG; Busch DH; Burdach S; Thiel U
    Oncotarget; 2016 Aug; 7(35):56584-56597. PubMed ID: 27447745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell engineering for cancer immunotherapy.
    Sadelain M
    Cancer J; 2009; 15(6):451-5. PubMed ID: 20010162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ; Weil DP; Shamamian P; Rivoltini L; Kawakami Y; Topalian S; Jennings C; Eliyahu S; Rosenberg SA; Nishimura MI
    Cancer Res; 1994 Oct; 54(20):5265-8. PubMed ID: 7522957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.